Bioterrorism Present
-
Upload
society-of-thai-emergency-physicians -
Category
Health & Medicine
-
view
31.952 -
download
0
Transcript of Bioterrorism Present
![Page 1: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/1.jpg)
นพ. อินทนนท์ อ่ิมสุวรรณ โครงการจัดต้ังภาควิชาเวชศาสตร์ฉุกเฉิน
คณะแพทยศาสตร์ มหาวิทยาลัยธรรมศาสตร์
![Page 2: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/2.jpg)
Ä On October 2, 20010 a 63-year-old Caucasian photo editor
working for a Florida newspaper o awoke early with nausea, vomiting, and
confusion and was taken to a local emergency room for evaluation
![Page 3: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/3.jpg)
P His illness, which started on September 27 during a trip to North Carolina
characterized by malaise, fatigue, fever, chills, anorexia, and sweats
, No history of headache, cough, chest pain, myalgias, dyspnea, abdominal pain, diarrhea, or skin lesions
![Page 4: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/4.jpg)
� Patient was alert and interactive but spoke nonsensically
l He was not oriented to person, place, or time
t BT 39.2°C HR 109/min BP 110/80 RR 14/min
0 Initial pulmonary, heart, and abdominal examinations were normal
e No nuchal rigidity
![Page 5: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/5.jpg)
![Page 6: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/6.jpg)
ü CBC: Hct 45.7 WBC 9400 N 76% L15% Plt 109,000
C Na 132 K 3.5 Cl 110 HCO3 241 UA :no RBC,WBC
![Page 7: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/7.jpg)
![Page 8: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/8.jpg)
l prominent superior mediastinum and small left pleural effusion
![Page 9: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/9.jpg)
0 WBC count 4,750/µL (81% neutrophils)µ RBC count 1,375/µLµ glucose 57 mg/dL (serum glucose 174
mg/dL) protein 666 mg/dL
![Page 10: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/10.jpg)
ü Microscopy examination of the CSF showed many gram-positive bacilli
![Page 11: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/11.jpg)
![Page 12: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/12.jpg)
![Page 13: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/13.jpg)
![Page 14: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/14.jpg)
ü Shortly after admissionm He had generalized seizures and was
intubated for airway protection
![Page 15: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/15.jpg)
![Page 16: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/16.jpg)
ü The patient died on October 5 Autopsy findings
hemorrhagic mediastinal lymphadenitis immunohistochemical staining showed
disseminated B. anthracis in multiple organs
![Page 17: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/17.jpg)
![Page 18: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/18.jpg)
l a 59-year-old Caucasian man, contract employee at a U.S. State Department mail sorting facility that received mail from the District of Columbia postal facility became ill
![Page 19: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/19.jpg)
ü He had drenching sweats 2 days of fever with chills,severe
myalgias w cough with scant white sputum substernal chest pain nausea, vomiting, abdominal pain
![Page 20: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/20.jpg)
ü BT 38.2°C HR 116/min BP 120/70 RR 16/min
/ oxygen saturation 94% (room air)n He appeared ill and had decreased
breath sounds at the right base The rest of the examination was
unremarkable
![Page 21: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/21.jpg)
ì Hematocrit 48.1%ì WBC count 9,500/mm3 ( 81% N, 9% L
9% M)m Platelet count 196,000/ mm3
9 Normal electrolytes and creatinine
![Page 22: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/22.jpg)
![Page 23: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/23.jpg)
� Widening mediastinum
![Page 24: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/24.jpg)
![Page 25: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/25.jpg)
Mediastinal adenopathy with evidence of hemorrhage
Normal lung parenchymaSmall bilateral pleural effusionsSuspected small pericardial effusion
![Page 26: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/26.jpg)
° Intravenous penicillin c Rifampin c Ciprofloxacinc Vancomycin
![Page 27: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/27.jpg)
![Page 28: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/28.jpg)
Features that should alert possibility of bioterrorism-related outbreak
r A rapidly increasing disease incidence
(e.g., within hours or days) in a normally
healthy population
o An epidemic curve that rises and falls
during a short period of time
t especially with fever, respiratory, or
gastrointestinal complaints
![Page 29: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/29.jpg)
Ä An endemic disease rapidly emerging at an uncharacteristic time or in an unusual pattern
Lower attack rates among people who had been indoorsespecially in areas with filtered air or closed
ventilation systems compared with people who had been outdoors
s Clusters of patients arriving from a single locale
Features that should alert possibility of bioterrorism-related outbreak
![Page 30: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/30.jpg)
ü Large numbers of rapidly fatal casess Any patient presenting with uncommon
disease and has bioterrorism potential Pulmonary anthraxTularemiaPlague
Features that should alert possibility of bioterrorism-related outbreak
![Page 31: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/31.jpg)
Ä The U.S. Public health system and primary healthcare providers must be prepared to address various biological agents
b pathogens that are rarely seen in the united states
r High-priority agents include organisms that pose a risk to national security
![Page 32: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/32.jpg)
P Category A agentsCan be easily disseminated or transmitted
from person to personResult in high mortality rates and have the
potential for major public health impactMight cause public panic and social
disruptionRequire special action for public health
preparedness
![Page 33: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/33.jpg)
� Anthrax (bacillus anthracis) i Botulism (clostridium botulinum toxin) 1 Plague (yersinia pestis) H Smallpox (variola major) a Tularemia (francisella tularensis) r Viral hemorrhagic fever
filoviruses [Ebola, marburg] arenaviruses [Lassa, machupo]
![Page 34: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/34.jpg)
ü Biological weaponIn year 2001, USAnthrax was deliberately spread through the
postal system by sending letters with powder containing anthrax
22 cases of anthrax infection
![Page 35: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/35.jpg)
P Bacillus anthracisi a gram-positive spore-forming
bacteriums “woolsorters'disease”a a disease of sheep, cattle, and horses
![Page 36: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/36.jpg)
![Page 37: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/37.jpg)
ü The spores are extremely hardy and can survive for years
s The disease is caused by exposure to the spores, not the bacilli in their vegetative state
![Page 38: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/38.jpg)
ü The spores germinate into bacilli inside macrophages
n Releasing toxins protective antigenedema factorlethal factor
O cause edema and cell death
![Page 39: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/39.jpg)
� Skin : cutaneous anthraxx Lung : inhalation anthrax
Breathing in anthrax spores from infected animal products like wool
l GI tract : gastrointestinal anthraxEating undercooked meat from infected
animals
![Page 40: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/40.jpg)
![Page 41: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/41.jpg)
ü Incubation periodd ranges from 1day to 8 weeks (average
5days) depending on the exposure route and dose 2-60 days following pulmonary exposure 1-7 days following cutaneous exposure 1-7 days following ingestion
![Page 42: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/42.jpg)
0 the most lethal form of the disease f caused by inhaling spores into the lungsn the spores germinate and are
transported to the tracheobronchial lymph nodes
![Page 43: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/43.jpg)
Initial phaseð flulike illness with malaisew nonproductive cough, chest discomfortu initial phase can be delayed for more
than a month in some patientss 50% of patients develop hemorrhagic
meningitis
![Page 44: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/44.jpg)
ü Within 24 to 48 hoursh abrupt deterioration
Overwhelming sepsisDyspnea, stridorShockHemorrhagic mediastinitis
![Page 45: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/45.jpg)
� Chest radiograph show a widened mediastinum and hilar adenopathy
![Page 46: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/46.jpg)
Mediastinal widening and pleural effusion
![Page 47: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/47.jpg)
ü CT chest is more sensitiveBloody pleural effusions consolidation of the lung fields
![Page 48: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/48.jpg)
H Clinical diagnosisFlulike or septic illness
c A reason to consider anthrax in the first place Current outbreak, warning from authorities
, Sputum culture, gram stain, and blood cultures are not helpful until late in the course of the disease
![Page 49: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/49.jpg)
ü Tests to confirm the diagnosis PCR for identification of anthrax markers
in pleural fluidi serologic detection of immunoglobulin to
protective antigene Immunohistochemical testing of biopsy
specimens
![Page 50: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/50.jpg)
l Influenza
![Page 51: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/51.jpg)
� spores are introduced into the skin through open wounds or abrasions
n After I.P. 1 to 5 days5 Begins as a papule usually on an
exposed areathe head, neck, or an upper extremity
o The papule may resemble an insect or spider bite and may itch
![Page 52: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/52.jpg)
ü a papule progressing to form a large vesicle over the next several days
e Severe edema occurs around the lesion with regional lymphadenitis
m The lesions are not tenderm patient may or may not be febrile
![Page 53: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/53.jpg)
Day 2 Day 4
![Page 54: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/54.jpg)
Day 4 : edema Day 4 : Eschar formation
![Page 55: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/55.jpg)
ü After about 1 weekü the lesion ruptures, forming a black
eschar r surrounding erythema and edema
increaseh The necrotic ulcer is usually painless
![Page 56: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/56.jpg)
Ulcer and vesicle ringblack eschar
![Page 57: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/57.jpg)
� Forearm lesion on day 7n vesiculation and ulceration of initial macular or
papular anthrax skin lesion
![Page 58: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/58.jpg)
h Eschar of the neck on day 15, typical of the last day of lesion
![Page 59: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/59.jpg)
![Page 60: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/60.jpg)
![Page 61: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/61.jpg)
ü In the next 2 to 3 weeksü the eschar sloughs off f the organism disseminates and the
patient dies
![Page 62: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/62.jpg)
ü The mortality rate 20% without treatment 1% with treatment
t Antibiotics do not affect the course of local disease
e but are used to prevent dissemination and death
![Page 63: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/63.jpg)
H Clinical diagnosis.i Confirmation
Culturing of the lesion, punch biopsy,or serologic testing
![Page 64: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/64.jpg)
l Rare manifestations o The ingestion of insufficiently cooked,
contaminated meatt the spores are transported to regional
lymphatic tissuer I.P 2- 5 dayr The mortality rate is 50%
![Page 65: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/65.jpg)
0 Present with sore throat and neck swelling from cervical and submandibular lymphadenitis
m The tonsils are frequently involvedi Fever and toxicityt Dysphagia t Respiratory distress
![Page 66: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/66.jpg)
� Begins with nausea, vomiting, and fever e Hematemesise Ascitese Bloody diarrhea e Mesenteric lymphadenitisa Present with an acute abdomen
![Page 67: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/67.jpg)
![Page 68: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/68.jpg)
Rosen's Emergency Medicine: Concepts and Clinical Practice, 6th Ed
![Page 69: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/69.jpg)
, Death usually results within 3 dayss The mortality rate was thought to
exceed 90%
![Page 70: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/70.jpg)
� Inactivated, cell-free anthrax vaccinel There is a vaccine to prevent anthrax, but it
is not yet available for the general publica Anyone who may be exposed to anthrax
Certain members of the USArmed forcesLaboratory workersWorkers who may enter contaminated areasIn the event of an attack using anthrax as a
weapon, people exposed would get the vaccine
![Page 71: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/71.jpg)
� Human-to-human transmission has not been reported with inhalational anthrax
t Airborne transmission does not occur, but direct contact with skin lesions may result in cutaneous infection
![Page 72: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/72.jpg)
![Page 73: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/73.jpg)
![Page 74: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/74.jpg)
![Page 75: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/75.jpg)
![Page 76: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/76.jpg)
è Yersinia pestisà gram-negative bacterium c Zoonotic disease is transmitted to
humans by the bites of infected rodent fleas
![Page 77: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/77.jpg)
Male Xenopsylla cheopis (oriental rat flea) engorged with blood. This flea is the primary vector of plague in most large plague epidemics in Asia, Africa, and South America
![Page 78: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/78.jpg)
è suggestive of exposure to rodents, rodent fleas, wild rabbits, sick or dead carnivores, or patients with pneumonic plague.
a Incubation period is 1–6 days
![Page 79: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/79.jpg)
![Page 80: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/80.jpg)
![Page 81: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/81.jpg)
, Specimensbubo aspirates, blood cultures, sputum
culture if pneumonic
o Microscopic identificationt culture confirmationt Serologic tests
fourfold change in antibody titer to f1 antigen between acute- and convalescent-phase sera
![Page 82: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/82.jpg)
� Physicians should report all suspected plague cases to state or local health departments and/or consult with CDC to obtain information and access diagnostic services.
![Page 83: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/83.jpg)
![Page 84: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/84.jpg)
( Parenteral antibiotic therapy Streptomycin
O AlternativelyGentamicin
¤ Oral therapyDoxycycline
![Page 85: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/85.jpg)
ì No vaccine is currently available in the united states.
i aimed at reducing contact with fleas and potentially infected rodents and other wildlife
![Page 86: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/86.jpg)
![Page 87: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/87.jpg)
ü Generated by the infected patient during coughing, sneezing, talking during
respiratory-care procedures
![Page 88: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/88.jpg)
ü Healthcare providers and others should wear a surgical-type mask when within 3 feet of the infected patient
c Some healthcare facilities require a mask be worn to enter the room of a patient on droplet precautions
![Page 89: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/89.jpg)
ü Maintained until patient has completed 72 hours of antimicrobial therapy
![Page 90: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/90.jpg)
![Page 91: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/91.jpg)
ü Maintaining spatial separation of at least 3 feet between infected patients and others when cohorting is not achievable.
r Avoiding placement in the same room with an immunocompromised patient.
m Special air handling is not necessary and doors may remain open
![Page 92: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/92.jpg)
0 Prophylactic antibiotic treatment in person who exposure to bites of wild rodent fleas during an outbreaktissues of a plague-infected animalperson or animal with suspected plague
pneumonia
![Page 93: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/93.jpg)
![Page 94: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/94.jpg)
![Page 95: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/95.jpg)
![Page 96: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/96.jpg)
![Page 97: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/97.jpg)
![Page 98: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/98.jpg)
![Page 99: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/99.jpg)
![Page 100: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/100.jpg)
![Page 101: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/101.jpg)
![Page 102: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/102.jpg)
![Page 103: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/103.jpg)
![Page 104: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/104.jpg)
![Page 105: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/105.jpg)
![Page 106: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/106.jpg)
![Page 107: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/107.jpg)
![Page 108: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/108.jpg)
![Page 109: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/109.jpg)
![Page 110: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/110.jpg)
ü Contact precautionsWear clean gloves upon entry into patient
room.Wear gown for all patient contact and for all
contact with the patient’s environment.Require a gown be worn to enter the room of
a patient.Gown must be removed before leaving the
patient’s room.Wash hands using an antimicrobial agent
![Page 111: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/111.jpg)
![Page 112: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/112.jpg)
ü Healthcare facilities without patient rooms appropriate for Airborne Precautions
e should have a plan for transfer of suspected or confirmed smallpox patients to neighboring facilities with appropriate isolation rooms
![Page 113: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/113.jpg)
![Page 114: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/114.jpg)
![Page 115: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/115.jpg)
Ð Fever, headache and stiff neck a sepsis and rash in meningococcemia
![Page 116: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/116.jpg)
H N. meningitidis colonizes mucosal surfaces of nasopharynx
p direct contact with large droplet respiratory secretions from the patients or asymptomatic carriers
c Humans are the only host
![Page 117: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/117.jpg)
H Patients with meningococcemia should be placed in respiratory isolation for at least 24 hours.
![Page 118: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/118.jpg)
H Close contacts should receive antibiotic prophylaxis.
h Household, nursery school, and daycare center contacts
r Intimate contacts and health care workers with intimate exposure mouth-to-mouth resuscitation, intubation,suctioning
![Page 119: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/119.jpg)
ü Rifampin, 10 mg/kg (up to 600 mg) orally every 12 hours for four doses
h The dose for infants younger than 1 month is 5 mg/kg.
. Rifampin discolors the urine r Contact lenses should be removed to
avoid permanent staining.
![Page 120: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/120.jpg)
ü Ceftriaxone IM is effective against group A strains. 125 mg for children younger than 12 years 250 mg for those older than 12 yearsalternative for pregnant women and for
people in whom compliance cannot be ensured.
o Ciprofloxacin (500 mg orally)
![Page 121: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/121.jpg)
È Meningococcal vaccine should be considered adjunct to prophylaxis in epidemics close contacts in sporadic cases
n The currently available vaccine is a quadrivalent vaccine containing purified capsular polysaccharides
for groups A, C, Y, W
![Page 122: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/122.jpg)
ü No vaccine exists for group Bthe most prevalent serogroup in the United
States.
![Page 123: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/123.jpg)
ü The quadrivalent vaccine is not recommended for routine use
r but should be administered tochildren 2 years of age older in high-risk groupsfunctional or anatomic asplenia terminal complement deficiency
![Page 124: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/124.jpg)
ü The vaccine is currently administered to U.S. military recruits.
c Consideration in people traveling to endemic areas of the world such as sub-Saharan Africa.
![Page 125: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/125.jpg)
![Page 126: Bioterrorism Present](https://reader033.fdocuments.net/reader033/viewer/2022060107/554b649eb4c9051b458b53d1/html5/thumbnails/126.jpg)